Had the pleasure of interviewing FDA Commissioner @SGottliebFDA this afternoon on all things biosimilars, generic drug labels, opioids, CRLs, and areas where he's felt it's been important to change the narrative
Conversation
Replying to
couple highlights: In the next 6-12 mos., FDA will be releasing a new doc. when drugs are approved on the agency's thought process. CRL release is still under consid., and opioids, drug pricing and tobacco were 3 areas where he said he's consciously tried to change the narrative
3
3
Replying to
You got to meet the man that’s gonna be responsible for higher crime, incarceration’s and deaths due to a lot of people turning to street drugs. The guy is more deplorable then hillary.



